文献速递胸部技术与安全DRCT

意大利COVID-19疫情:用于量化和监测疾病进展的实验性胸部X线评分系统

COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression.
PubMed 文献 · Radiol Med · 2020-05-01

本文介绍了一套用于量化与监测COVID-19肺炎严重程度及进展的实验性胸部X线评分系统,并报告了对100例住院SARS-CoV-2感染患者的初步验证结果,这些患者均有最终结局(康复或死亡)可供分析。作者认为在当前应急环境下,胸部X线可作为监测感染患者肺部异常快速进展的有用诊断工具,尤其在重症监护病房。

要点

  • 胸部X线在早期病变检出上不敏感,但可用于监测住院COVID-19患者肺部异常的快速进展。
  • 作者提出实验性CXR评分系统,用于量化和监测COVID-19肺炎的严重程度与进展。
  • 初步验证纳入100例住院SARS-CoV-2感染患者,均有最终结局(康复或死亡)。

核心结论

  • 作者认为在当前应急环境下,胸部X线可作为监测感染患者肺部异常快速进展的有用诊断工具,尤其在重症监护病房。
  • 作者提出并正在应用一套实验性CXR评分系统,用于量化和监测COVID-19肺炎的严重程度与进展。
  • 作者报告了对100例住院SARS-CoV-2感染患者的初步验证研究结果,这些患者均有最终结局(康复或死亡)可供分析。

研究设计与样本

  • 短篇通讯,介绍作者正在使用的实验性CXR评分系统。
  • 初步验证研究样本为100例住院SARS-CoV-2感染患者,均有最终结局(康复或死亡)可供分析。
  • 原文未报告中心数、设备或参考标准。

临床应用与阅片要点

  • 胸部CT目前被认为是检测早期病变及定量评估COVID-19肺炎严重程度与进展的最有效方法。
  • 胸部X线被认为对早期肺部病变检出不敏感,但作者认为在应急环境下可用于监测感染患者肺部异常的快速进展,尤其在重症监护病房。
  • 作者提出实验性CXR评分系统用于量化和监测COVID-19肺炎的严重程度与进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new virus recently isolated from humans. SARS-CoV-2 was discovered to be the pathogen responsible for a cluster of pneumonia cases associated with severe respiratory disease that occurred in December 2019 in China. This novel pulmonary infection, formally called Coronavirus Disease 2019 (COVID-19), has spread rapidly in China and beyond. On 8 March 2020, the number of Italians with SARS-CoV-2 infection was 7375 with a 48% hospitalization rate. At present, chest-computed tomography imaging is considered the most effective method for the detection of lung abnormalities in early-stage disease and quantitative assessment of severity and progression of COVID-19 pneumonia. Although chest X-ray (CXR) is considered not sensitive for the detection of pulmonary involvement in the early stage of the disease, we believe that, in the current emergency setting, CXR can be a useful diagnostic tool for monitoring the rapid progression of lung abnormalities in infected patients, particularly in intensive care units. In this short communication, we present our experimental CXR scoring system that we are applying to hospitalized patients with COVID-19 pneumonia to quantify and monitor the severity and progression of this new infectious disease. We also present the results of our preliminary validation study on a sample of 100 hospitalized patients with SARS-CoV-2 infection for whom the final outcome (recovery or death) was available.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Borghesi A, Maroldi R. COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression. Radiol Med. 2020. PMID: 32358689. doi:10.1007/s11547-020-01200-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。